Loading...
Market
How will Bristol-Myers and Sanofi's global sales be affected in 2024?
5
Resolution / Starting Odds
Increase in sales • 33%
Decrease in sales • 33%
No significant change • 34%
Annual financial reports
Story
Bristol-Myers and Sanofi Ordered to Pay $916 Million in Hawaii Plavix Case on May 21, 2024
May 22, 2024, 04:12 PM
A judge in Hawaii has ordered Bristol-Myers Squibb Co. and Sanofi to pay more than $916 million to the state for failing to warn non-white patients, particularly those of East Asian or Pacific Island ancestry, about potential health risks associated with their blood thinner Plavix. The ruling, issued on Tuesday, May 21, 2024, increases the companies' liability from an earlier judgment of $834 million.
View original story
Similar markets
Outperform • 33%
Underperform • 33%
Match • 33%
Becomes a top 5 vaccine company • 25%
Remains outside top 5 but improves position • 25%
No significant change in market position • 25%
Declines in market position • 25%
Increase • 33%
No significant change • 33%
Decrease • 33%
Less than 5% • 25%
5%-10% • 25%
10%-15% • 25%
More than 15% • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Bristol-Myers Squibb • 25%
Novavax outperforms Sanofi • 50%
Sanofi outperforms Novavax • 50%